Personalized Noninvasive Support

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Acute Hypoxic Respiratory Failure

Treatments

Device: Noninvasive support

Study type

Interventional

Funder types

Other

Identifiers

NCT06202144
5173-2

Details and patient eligibility

About

The optimal noninvasive respiratory support for acute hypoxemic respiratory failure is debated. Recent preliminary data indicate that both pressure-support noninvasive ventilation (NIV) and continuous-positive airway pressure (CPAP) may be of benefit. While often applied interchangeably in clinical practice, NIV and CPAP have different effects on the inspiratory effort, which is the major determinant of self-inflicted lung injury. Also, inspiratory effort widely varies among individuals. The purpose of this study is to assess the physiological effects of a noninvasive respiratory support approach guided by inspiratory effort, as compared to CPAP and NIV, in patients with moderate-to-severe acute hypoxemic respiratory failure.

Full description

Patients with acute hypoxemic respiratory failure will undergo a decremental pressure-support trial during helmet noninvasive support. The following pressure-support settings will be applied sequentially, with positive end-expiratory pressure kept constant and equal to 10-12 cmH2O: 20 cmH2O, 16 cmH2O, 12 cmH2O, 8 cmH2O and high-flow-driven CPAP. Inspiratory effort will be monitored during the trial through esophageal manometry. The personalized setting of noninvasive support will be defined as the minimal pressure-support level capable of generating inspiratory effort between 5 and 10 cmH2O. Personalized noninvasive support will be then compared to conventionally-set NIV and CPAP in a randomized cross-over trial.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute hypoxemic respiratory failure and PaO2/FiO2<200 mmHg
  • PaCO2<45 mmHg
  • Respiratory failure not caused by exacerbation of chronic pulmonary disease, cardiac failure or fluid overload

Exclusion criteria

  • Pregnancy
  • Contraindication to helmet support
  • Contraindication to esophageal manometry
  • Contraindication to electrical-impedance tomography monitoring
  • Recent surgery involving the abdomen or the thorax
  • Pneumothorax or documented barotrauma

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

20 participants in 3 patient groups

Personalized Noninvasive support
Experimental group
Description:
Helmet noninvasive support, with positive end-expiratory pressure (PEEP)=12 cmH2O and the minimal pressure-support level capable of generating inspiratory effort between 5 and 10 cmH2O
Treatment:
Device: Noninvasive support
Continuous positive airway pressure
Active Comparator group
Description:
Helmet CPAP will be delivered through a high-flow generator and PEEP valve set at 12 cmH2O
Treatment:
Device: Noninvasive support
Noninvasive ventilation
Active Comparator group
Description:
Helmet NIV will be delivered in the pressure-support mode, with PEEP=12 cmH2O and pressure support=12 cmH2O
Treatment:
Device: Noninvasive support

Trial contacts and locations

1

Loading...

Central trial contact

Domenico Luca Grieco, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems